SVF (Stromal Vascular Fraction) therapy has become an increasingly discussed topic in regenerative orthopedics, particularly among patients seeking joint-preserving treatment options for Hip Avascular Necrosis (AVN) and Knee Osteoarthritis. Derived from a patient's own adipose (fat) tissue, SVF contains a variety of biologically active cells that are being studied for their role in supporting tissue health, cellular signaling, and natural healing processes.
As awareness of regenerative medicine grows, more patients are exploring therapies that focus on maintaining mobility and preserving joint function rather than addressing symptoms alone.
In India, SVF-based procedures are being utilized by orthopedic and regenerative medicine specialists in selected cases as part of individualized treatment planning. While regenerative medicine continues to evolve and ongoing research is expanding our understanding of these therapies, interest in SVF has increased because of its minimally invasive nature and its use of the patient's own tissue.
For individuals diagnosed with Hip AVN or Knee Osteoarthritis, consulting an experienced orthopedic specialist remains the most important step in understanding available treatment options and determining the most appropriate approach based on their specific condition.
Powered by Froala Editor
You may also like
More from this category.